Prediction: Lilly Will Trade at $1,200 by Year-End
Investors weigh a bold forecast that Eli Lilly could hit $1,200 by year-end 2026, betting on GLP-1 drugs and a robust...
Index level data represents a snapshot of market values at a given time. This explanation covers how levels are computed and used in analysis.
24,561 articlesInvestors weigh a bold forecast that Eli Lilly could hit $1,200 by year-end 2026, betting on GLP-1 drugs and a robust...
A New York court fight over dormant Bitcoin faces a direct on-chain challenge as billions of dollars in BTC move from...
A wave of AI investment is being financed with debt rather than cash, totaling roughly $750 billion this year. Invest...
As policy moves accelerate quantum adoption, D-Wave and its peers spark trading activity. This deep dive explains wha...
American Express has carved a niche by serving high-spending clients with premium perks. This article explores whethe...
U.S. equity markets tumbled as traders priced in a looming memory supply crisis in chipmakers, triggering a broad tec...
A Vesta director recently sold roughly $203,000 worth of stock while the company’s shares have risen about 25% over t...
Microsoft shares have fallen sharply this year, yet bulls argue that cloud growth and AI initiatives underpin a resil...
Retail traders surged through May and June 2026, lifting volumes and reshaping daily moves. Five charts reveal how ch...
A deep dive into the hidden costs behind a record wealth year linked to branding, properties, and regulatory exposure...
A free cash flow ETF is delivering a surprising edge in 2026, outperforming the S&P 500 as investors rotate toward ca...
Alphabet stock doubled year as the tech giant rode AI optimism and cloud growth. This guide breaks down what happened...